89 related articles for article (PubMed ID: 27488155)
1. Prostaglandin-associated periorbitopathy.
Shrirao N; Khurana M; Mukherjee B
Indian J Ophthalmol; 2016 Jun; 64(6):459. PubMed ID: 27488155
[No Abstract] [Full Text] [Related]
2. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
[TBL] [Abstract][Full Text] [Related]
3. Clicking Eyelids: A New Finding of Prostaglandin-Associated Periorbitopathy.
Skorin L; Dailey KH
Optom Vis Sci; 2016 Jul; 93(7):779-81. PubMed ID: 27055061
[TBL] [Abstract][Full Text] [Related]
4. Latanoprost-induced prostaglandin-associated periorbitopathy.
Tan J; Berke S
Optom Vis Sci; 2013 Sep; 90(9):e245-7; discussion 1029. PubMed ID: 23912967
[TBL] [Abstract][Full Text] [Related]
5. Audible blink in prostaglandin-associated periorbitopathy.
Fong CS; Rajak SN; Pirbhai A; Selva D
Clin Exp Ophthalmol; 2016 Sep; 44(7):630-631. PubMed ID: 26872687
[No Abstract] [Full Text] [Related]
6. Bimatoprost (0.03%)-induced accommodative spasm and pseudomyopia.
Padhy D; Rao A
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26598527
[TBL] [Abstract][Full Text] [Related]
7. Bimatoprost-induced chemical blepharoplasty.
Sarnoff DS; Gotkin RH
J Drugs Dermatol; 2015 May; 14(5):472-7. PubMed ID: 25942665
[TBL] [Abstract][Full Text] [Related]
8. Bimatoprost-induced iris hyperpigmentation: beauty in the darkened eye of the beholder.
Lipp MB; Athalye L; Nami N
Cutis; 2019 Aug; 104(2):E7-E9. PubMed ID: 31603967
[No Abstract] [Full Text] [Related]
9. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
[TBL] [Abstract][Full Text] [Related]
10. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.
Wanichwecha-Rungruang B; Iemsomboon W
J Med Assoc Thai; 2005 Sep; 88(9):1228-35. PubMed ID: 16536109
[TBL] [Abstract][Full Text] [Related]
12. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.
Chen YY; Wang TH; Liu C; Wu KY; Chiu SL; Simonyi S; Lu DW
BMC Ophthalmol; 2016 Sep; 16(1):162. PubMed ID: 27633513
[TBL] [Abstract][Full Text] [Related]
14. Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring.
Brandt JD; DuBiner HB; Benza R; Sall KN; Walker GA; Semba CP;
Ophthalmology; 2017 Oct; 124(10):1565-1566. PubMed ID: 28528010
[No Abstract] [Full Text] [Related]
15. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
[TBL] [Abstract][Full Text] [Related]
16. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
Zhong Y; Shen X; Yu J; Tan H; Cheng Y
Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin-Associated Enophthalmos: An Observer-Masked Radiological Study of Patients Treated with Prostaglandin Drops to One Eye Only.
Joganathan V; Aboelmagd SM; Eke T
Orbit; 2015; 34(6):336-7. PubMed ID: 26540119
[No Abstract] [Full Text] [Related]
18. Periocular cutaneous pigmentary changes associated with bimatoprost use.
Galloway GD; Eke T; Broadway DC
Arch Ophthalmol; 2005 Nov; 123(11):1609-10. PubMed ID: 16286629
[No Abstract] [Full Text] [Related]
19. The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations.
Wierzbowska J; Łagocka A; Siemiatkowska A; Robaszkiewicz J; Stankiewicz A; Sierdziński J
Klin Oczna; 2009; 111(10-12):323-6. PubMed ID: 20169887
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products.
Steinsapir KD; Steinsapir SMG
Dermatol Surg; 2021 May; 47(5):658-665. PubMed ID: 33625141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
